Edouard Reizine

7PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersCross-sectional analysisCondensed matter imagingMedical biochemistry - lipidsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 27, 2024
Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.

Roberto Cannella, Francesco Matteini, Marco Dioguardi Burgio

|Dec 12, 2023
Glomerular Filtration Rate Measured Based on Iomeprol Clearance Assessed at CT Urography in Living Kidney Donor Candidates.

Thomas Stehlé, Félix Wei, Séverine Brabant

|Sep 04, 2023
Applicability of Bosniak 2019 for renal mass classification on portal venous phase at the era of spectral CT imaging using rapid kV-switching dual-energy CT.

Edouard Reizine, Maxime Blain, Lorenzo Pescatori

|Jun 07, 2022
Fat in mass in primary liver lesions: are usual MRI diagnostic criteria of both malignant and benign liver lesions still applicable?

Edouard Reizine, Azure Meurgey, Giuliana Amaddeo

|Nov 04, 2020
Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.

E Reizine, M Ronot, M Ghosn

|Feb 06, 2020
Reply to "Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia".

Edouard Reizine, Alain Luciani

Pageof 2

Frequent Collaborators

3 joint publications

Alain Luciani

2 joint publications

Frédéric Pigneur

2 joint publications

Thomas Stehlé

1 joint publications

Mario Ghosn